Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Western blot (applications tested for the base form of this product only)
Human KLK13 / Kallikrein 13
Human, Dog, Horse (tested or 100% immunogen sequence identity)
(applications tested for the base form of this product only)
Specificity and Use
KLK13 / Kallikrein 13 antibody was raised against synthetic peptide located between aa87-136 of human KLK13 (Q9UKR3, NP_056411). Percent identity by BLAST analysis: Human, Chimpanzee, Dog, Horse (100%); Bovine (85%).
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer.
KLK13 / Kallikrein 13 antibody Western Blot of Esophagus Tumor. Antibody dilution: 1 ug/ml. This image was taken for the base form of this product. Alternate forms, such as conjugated, azide-free, or ready-to-use, have not been tested.
Requested From: United States
Date Requested: 10/24/2016